Filing Details
- Accession Number:
- 0001209191-23-013685
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-28 16:40:33
- Reporting Period:
- 2023-02-24
- Accepted Time:
- 2023-02-28 16:40:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1550395 | David Altshuler | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Global Research And Cso | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-02-24 | 3,970 | $289.12 | 36,276 | No | 4 | F | Direct | |
Common Stock | Disposition | 2023-02-27 | 3,636 | $287.23 | 32,640 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-02-27 | 300 | $288.74 | 32,340 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-02-27 | 302 | $289.60 | 32,038 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1.
- Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $287.23 (range $286.80 to $287.72).
- Open market sales reported on this line occurred at a weighted average price of $288.74 (range $288.42 to $289.37).
- Open market sales reported on this line occurred at a weighted average price of $289.60 (range $289.49 to $289.65).